Progyny (PGNY) Competitors

Progyny logo
$22.60 -0.13 (-0.55%)
As of 11:01 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PGNY vs. GH, OPCH, RDNT, BTSG, SHC, VCYT, SGRY, LFST, CON, and PRVA

Should you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

Progyny vs.

Guardant Health (NASDAQ:GH) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends.

Progyny has a net margin of 5.03% compared to Guardant Health's net margin of -74.02%. Progyny's return on equity of 11.36% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-74.02% -1,200.44% -29.88%
Progyny 5.03%11.36%7.87%

In the previous week, Guardant Health had 2 more articles in the media than Progyny. MarketBeat recorded 7 mentions for Guardant Health and 5 mentions for Progyny. Progyny's average media sentiment score of 1.06 beat Guardant Health's score of 0.76 indicating that Progyny is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Progyny
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Guardant Health currently has a consensus price target of $42.63, indicating a potential downside of 10.56%. Progyny has a consensus price target of $25.50, indicating a potential upside of 12.86%. Given Progyny's higher possible upside, analysts clearly believe Progyny is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
3.00
Progyny
0 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.31

Progyny has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$563.95M10.44-$479.45M-$4.24-11.24
Progyny$1.09B1.77$62.04M$0.5838.96

Guardant Health received 184 more outperform votes than Progyny when rated by MarketBeat users. However, 70.92% of users gave Progyny an outperform vote while only 70.30% of users gave Guardant Health an outperform vote.

CompanyUnderperformOutperform
Guardant HealthOutperform Votes
284
70.30%
Underperform Votes
120
29.70%
ProgynyOutperform Votes
100
70.92%
Underperform Votes
41
29.08%

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 94.9% of Progyny shares are owned by institutional investors. 5.5% of Guardant Health shares are owned by company insiders. Comparatively, 12.3% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Guardant Health has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500.

Summary

Progyny beats Guardant Health on 13 of the 18 factors compared between the two stocks.

Get Progyny News Delivered to You Automatically

Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PGNY vs. The Competition

MetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$1.92B$2.30B$5.78B$9.09B
Dividend YieldN/A7.31%5.28%4.00%
P/E Ratio38.9617.6787.6618.39
Price / Sales1.778.881,022.5877.90
Price / Cash34.5210.5137.4433.55
Price / Book3.923.225.164.81
Net Income$62.04M$72.19M$108.96M$223.02M
7 Day Performance-4.01%-3.15%2.82%1.50%
1 Month Performance29.63%7.82%2.54%-0.57%
1 Year Performance-43.37%-14.22%26.30%24.02%

Progyny Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PGNY
Progyny
3.8337 of 5 stars
$22.60
-0.6%
$25.50
+12.9%
-41.5%$1.92B$1.09B38.96310Positive News
GH
Guardant Health
3.8839 of 5 stars
$47.07
+0.2%
$42.63
-9.4%
+123.6%$5.85B$692.26M-11.171,779
OPCH
Option Care Health
4.5488 of 5 stars
$30.82
-0.3%
$32.25
+4.6%
+0.3%$5.24B$4.30B25.887,802Positive News
RDNT
RadNet
3.7342 of 5 stars
$66.56
+1.7%
$75.50
+13.4%
+81.3%$4.93B$1.62B-951.2210,288News Coverage
BTSG
BrightSpring Health Services
2.96 of 5 stars
$23.65
+0.2%
$19.42
-17.9%
+110.8%$4.12B$8.83B-91.0035,000
SHC
Sotera Health
3.6555 of 5 stars
$13.68
-0.3%
$16.08
+17.6%
-8.6%$3.87B$1.05B54.703,000Positive News
VCYT
Veracyte
4.0266 of 5 stars
$45.23
-0.5%
$42.00
-7.1%
+84.3%$3.51B$361.05M-302.12790News Coverage
Gap Down
SGRY
Surgery Partners
2.9218 of 5 stars
$25.42
-0.3%
$36.56
+43.8%
-19.5%$3.23B$2.74B-52.9213,500
LFST
LifeStance Health Group
1.0102 of 5 stars
$8.08
+1.4%
$8.70
+7.7%
+43.0%$3.09B$1.06B-31.029,325Positive News
CON
Concentra Group Holdings Parent
N/A$23.29
-0.1%
$28.63
+22.9%
N/A$2.96B$1.84B0.0011,000Positive News
PRVA
Privia Health Group
2.7152 of 5 stars
$22.85
+0.0%
$24.88
+8.9%
+21.1%$2.74B$1.66B228.281,102

Related Companies and Tools


This page (NASDAQ:PGNY) was last updated on 2/6/2025 by MarketBeat.com Staff
From Our Partners